Entry onto the NewConnect market and advisory support for Massmedica sp. z o.o. in raising capital and investors (Q82020): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Label in wikidata changed) |
(Created claim: summary (P836): SA.42799 (2015/X) EC Regulation No 651/2014 Article 18 Aid for consultancy in favour of SMEs. the project aims to support the Applicant in access to the capital market and also to activate the market for investors by creating the conditions for initiating investor cooperation with the Company.The applicant assumes to have obtained no more than PLN 4 million.These measures will make it possible to significantly expand and expand the company’s bid...) |
||
| Property / summary | |||
SA.42799 (2015/X) EC Regulation No 651/2014 Article 18 Aid for consultancy in favour of SMEs. the project aims to support the Applicant in access to the capital market and also to activate the market for investors by creating the conditions for initiating investor cooperation with the Company.The applicant assumes to have obtained no more than PLN 4 million.These measures will make it possible to significantly expand and expand the company’s bid for an innovative product for the permanent restoration of collagen structures.The project involves the acquisition by the Company of consultancy services provided by Prometeia Capital sp. z o.o. (“Adviser”) in connection with the development of documentation in order to attract investors and recapitalise the Company.The adviser will prepare the following documents:Report by the Danish Intelligence Division, Company price, securities note, Investment investor, investor presentation, Information document, Information document, Information policy, and Confidential Information Service.The documentation will be used to carry out the issue and sale of shares.The consultant will carry out the examination of the Company and draw up the Due Diligence Report to determine the Company’s financial and legal position.Investors will be provided with the Company’s price, justifying the proposed price of the shares and of the Investment Teaser, providing concise information about the Company.The investors concerned will receive a securities note containing detailed information about the Company, the securities and the bid mechanisms.The investor’s presentation will be presented at meetings with the investors.An information document will be drawn up for the purpose of applying for the placing of shares on the NewConnect market.It will also be prepared to organise the procedure for the application of confidential information and the Company’s Information Policy, laying down rules for the circulation and presentation of information, in particular in view of the fact that it is necessary for the Company to fulfil its information obligations.All documents are necessary for the efficient and effective implementation of the project.Due to the innovative character of the plan (English) | |||
| Property / summary: SA.42799 (2015/X) EC Regulation No 651/2014 Article 18 Aid for consultancy in favour of SMEs. the project aims to support the Applicant in access to the capital market and also to activate the market for investors by creating the conditions for initiating investor cooperation with the Company.The applicant assumes to have obtained no more than PLN 4 million.These measures will make it possible to significantly expand and expand the company’s bid for an innovative product for the permanent restoration of collagen structures.The project involves the acquisition by the Company of consultancy services provided by Prometeia Capital sp. z o.o. (“Adviser”) in connection with the development of documentation in order to attract investors and recapitalise the Company.The adviser will prepare the following documents:Report by the Danish Intelligence Division, Company price, securities note, Investment investor, investor presentation, Information document, Information document, Information policy, and Confidential Information Service.The documentation will be used to carry out the issue and sale of shares.The consultant will carry out the examination of the Company and draw up the Due Diligence Report to determine the Company’s financial and legal position.Investors will be provided with the Company’s price, justifying the proposed price of the shares and of the Investment Teaser, providing concise information about the Company.The investors concerned will receive a securities note containing detailed information about the Company, the securities and the bid mechanisms.The investor’s presentation will be presented at meetings with the investors.An information document will be drawn up for the purpose of applying for the placing of shares on the NewConnect market.It will also be prepared to organise the procedure for the application of confidential information and the Company’s Information Policy, laying down rules for the circulation and presentation of information, in particular in view of the fact that it is necessary for the Company to fulfil its information obligations.All documents are necessary for the efficient and effective implementation of the project.Due to the innovative character of the plan (English) / rank | |||
Normal rank | |||
Revision as of 09:16, 4 March 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Entry onto the NewConnect market and advisory support for Massmedica sp. z o.o. in raising capital and investors |
Project in Poland financed by DG Regio |
Statements
100,000.0 zloty
0 references
270,600.0 zloty
0 references
45.45 percent
0 references
1 June 2017
0 references
30 April 2019
0 references
MASSMEDICA S.A.
0 references
SA 42799(2015/X) rozporządzenie KE nr 651/2014 Artykuł 18 Pomoc na usługi doradcze na rzecz MŚP Celem projektu jest wsparcie Wnioskodawcy w dostępie do rynku kapitałowego, a także aktywizacja rynku inwestorów poprzez tworzenie warunków inicjowania współpracy inwestorów ze Spółką. Wnioskodawca zakłada pozyskanie nie więcej niż 4 mln zł. Środki te pozwolą na znaczące rozwinięcie i poszerzenie oferty spółki o innowacyjny produkt służący do trwałej odbudowy struktur kolagenowych. Projekt obejmuje nabycie przez Spółkę usług doradczych świadczonych przez Prometeia Capital sp. z o.o. („Doradca”), związanych z opracowaniem dokumentacji w celu pozyskania inwestorów i dokapitalizowania Spółki. Doradca przygotuje następujące dokumenty: Raport Due Dilligence, Wycena Spółki, Dokument Ofertowy, Teaser Inwestycyjny, Prezentacja Inwestorska, Dokument Informacyjny, Politykę Informacyjną, Procedurę Obiegu Informacji Poufnych. Dokumentacja posłuży przeprowadzeniu emisji i sprzedaży akcji. Doradca przeprowadzi badanie Spółki i sporządzi Raport Due Dilligence celem określenia sytuacji finansowej i formalno-prawnej Spółki. Inwestorom zostanie dostarczona Wycena Spółki, uzasadniająca proponowaną cenę akcji oraz Teaser Inwestycyjny, przedstawiający zwięzłe informacje na temat Spółki. Zainteresowani inwestorzy otrzymają Dokument Ofertowy, zawierający szczegółowe informacje o Spółce, papierach wartościowych i mechanizmach oferty. Prezentacja Inwestorska zostanie zaprezentowana w trakcie spotkań z inwestorami. Dokument Informacyjny zostanie sporządzony na potrzeby ubiegania się o wprowadzenie akcji do obrotu na rynku NewConnect. Przygotowana zostanie także Procedura Obiegu Informacji Poufnych oraz Polityka Informacyjna Spółki, określająca zasady obiegu oraz prezentacji informacji, w szczególności z uwagi na konieczność wypełniania przez Spółkę obowiązków informacyjnych. Wszystkie dokumenty są niezbędne do sprawnej i skutecznej realizacji projektu. Z uwagi na innowacyjny charakter planowan (Polish)
0 references
SA.42799 (2015/X) EC Regulation No 651/2014 Article 18 Aid for consultancy in favour of SMEs. the project aims to support the Applicant in access to the capital market and also to activate the market for investors by creating the conditions for initiating investor cooperation with the Company.The applicant assumes to have obtained no more than PLN 4 million.These measures will make it possible to significantly expand and expand the company’s bid for an innovative product for the permanent restoration of collagen structures.The project involves the acquisition by the Company of consultancy services provided by Prometeia Capital sp. z o.o. (“Adviser”) in connection with the development of documentation in order to attract investors and recapitalise the Company.The adviser will prepare the following documents:Report by the Danish Intelligence Division, Company price, securities note, Investment investor, investor presentation, Information document, Information document, Information policy, and Confidential Information Service.The documentation will be used to carry out the issue and sale of shares.The consultant will carry out the examination of the Company and draw up the Due Diligence Report to determine the Company’s financial and legal position.Investors will be provided with the Company’s price, justifying the proposed price of the shares and of the Investment Teaser, providing concise information about the Company.The investors concerned will receive a securities note containing detailed information about the Company, the securities and the bid mechanisms.The investor’s presentation will be presented at meetings with the investors.An information document will be drawn up for the purpose of applying for the placing of shares on the NewConnect market.It will also be prepared to organise the procedure for the application of confidential information and the Company’s Information Policy, laying down rules for the circulation and presentation of information, in particular in view of the fact that it is necessary for the Company to fulfil its information obligations.All documents are necessary for the efficient and effective implementation of the project.Due to the innovative character of the plan (English)
0 references
Identifiers
POIR.03.01.05-14-0009/17
0 references